logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The concept of innovative drugs is once again on the rise, Haoyuan Medicine has surged more than 15%.

date
29/08/2025
The concept of innovative drugs has risen again, Haoyuan Pharmaceutical's stock has surged over 15%, and KangChen Pharmaceutical and HuaHai Pharmaceutical have hit the daily limit.
Latest
2 m ago
Fujing China Holdings (02497.HK) released its interim results, with a net profit of 31.607 million RMB, a year-on-year increase of 112.5%.
2 m ago
Huafu Fashion (002042.SZ) released its performance for the first half of the year, with a net profit attributable to the parent company of 25.0978 million yuan, a decrease of 43.98%.
2 m ago
Xingchen Technology: Intends to acquire 53.3087% equity of Furikun for 214 million yuan.
2 m ago
The Wharf Holdings (01168.HK) announces interim results. The company's attributable net loss is 507.1 million Hong Kong dollars, an increase of approximately 2.37 times year-on-year.
2 m ago
Runto Corporation: Net profit loss of 36,193,100 yuan in the first half of 2025
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.